Moreover, intake of products containing anthocyanins resulted in a significant decrease in ALT levels in NAFLD patients (Zhang et al., 2015), healthy subjects with borderline hepatitis (Oki et al., 2016; Suda et al., 2008), and diabetic patients (Stote et al., 2020) in some RCTs. The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.